Soluble Urokinase Plasminogen Activator Receptor: A Promising Biomarker for Mortality Prediction Among Critical ED Patients
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26041609 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Piotr Wozniak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Medical University of Gdansk, 80-210 Gdansk, Poland. Hauptthemen laut MEDLINE: Receptors, Urokinase Plasminogen Activator, Biomarkers, Critical Illness, Emergency Service, Hospital. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Patients admitted to the emergency department (ED) are a highly diverse group in terms of the risk of death. In overcrowded EDs, it becomes crucial to quickly and reliably estimate the risk of death or significant health deterioration. For this purpose, the concentration of soluble urokinase plasminogen activator receptor (suPAR) in plasma has been studied in recent years in various patient populations. In the present study, we tested the hypothesis that measuring suPAR upon the ED admission of critically ill patients can identify those at the highest mortality risk. To verify this hypothesis, we analyzed the relationship between suPAR plasma concentration, other biochemical parameters, and Early Warning Scores (EWSs) on admission and survival to hospital discharge. The study group consisted of 61 ED patients with priority 1 in the Manchester Triage System (MTS), excluding patients with illness caused by environmental factors. Positive correlations between suPAR and inflammatory parameters such as CRP and PCT, as well as the warning scales MEWS, MEDS, and qSOFA, were confirmed. Plasma suPAR concentration on admission was found to be a promising predictor of in-hospital mortality. The study indicated the potential prognostic value of suPAR as the mortality risk predictor for a specific population of critically ill ED patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Medical University of Gdansk, 80-210 Gdansk, Poland.
ORCID-Profile: Piotr Wozniak, Mariusz Sieminski
Zitieren
APA
Wozniak, P., Sieminski, M., Pyrzowski, J., Petrosjan, R., Głogowski-Kulasza, J., & Leszczyński-Czeczatka, J. (2025). Soluble Urokinase Plasminogen Activator Receptor: A Promising Biomarker for Mortality Prediction Among Critical ED Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041609
Vancouver
Wozniak P, Sieminski M, Pyrzowski J, Petrosjan R, Głogowski-Kulasza J, Leszczyński-Czeczatka J. Soluble Urokinase Plasminogen Activator Receptor: A Promising Biomarker for Mortality Prediction Among Critical ED Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041609
BibTeX
@article{Wozniak2025,
author = {Wozniak, Piotr and Sieminski, Mariusz and Pyrzowski, Jan and Petrosjan, Rafael and Głogowski-Kulasza, Jakub and Leszczyński-Czeczatka, Jakub},
title = {Soluble Urokinase Plasminogen Activator Receptor: A Promising Biomarker for Mortality Prediction Among Critical ED Patients},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26041609}
}
EUVIMED